C5 Inhibition in Secondary Thrombotic Microangiopathies: A Yet Unresolved Question.
作者信息
Werion Alexis, Rondeau Eric
机构信息
Intensive Care Nephrology and Transplantation Department, SINRA, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
出版信息
Kidney Int Rep. 2021 Feb 22;6(4):878-880. doi: 10.1016/j.ekir.2021.02.012. eCollection 2021 Apr.
Abstract
摘要
相似文献
1
C5 Inhibition in Secondary Thrombotic Microangiopathies: A Yet Unresolved Question.补体C5抑制在继发性血栓性微血管病中的作用：一个尚未解决的问题
Kidney Int Rep. 2021 Feb 22;6(4):878-880. doi: 10.1016/j.ekir.2021.02.012. eCollection 2021 Apr.
2
Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis-Induced Thrombotic Microangiopathies.C5抑制在特发性炎性肌病和硬皮病肾危象所致血栓性微血管病中的作用
Kidney Int Rep. 2021 Jan 29;6(4):1015-1021. doi: 10.1016/j.ekir.2021.01.021. eCollection 2021 Apr.
3
Complement Activation and Thrombotic Microangiopathies.补体激活与血栓性微血管病。
Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1719-1732. doi: 10.2215/CJN.05830519. Epub 2019 Nov 6.
4
Application of C5 inhibitors in glomerular diseases in 2021.2021年C5抑制剂在肾小球疾病中的应用
Kidney Res Clin Pract. 2022 Jul;41(4):412-421. doi: 10.23876/j.krcp.21.248. Epub 2022 Mar 15.
5
Thrombotic microangiopathies and antineoplastic agents.血栓性微血管病与抗肿瘤药物
Nephrol Ther. 2017 Apr;13 Suppl 1:S109-S113. doi: 10.1016/j.nephro.2017.01.016.
6
Thrombotic microangiopathies during pregnancy: The obstetrical and neonatal perspective.妊娠期血栓性微血管病：产科和新生儿学视角。
Eur J Obstet Gynecol Reprod Biol. 2019 Jun;237:7-12. doi: 10.1016/j.ejogrb.2019.03.018. Epub 2019 Mar 23.
7
Utility of Different Scoring Systems for the Diagnosis of Thrombotic Microangiopathies.不同评分系统在血栓性微血管病诊断中的应用价值
J Coll Physicians Surg Pak. 2023 May;33(5):539-543. doi: 10.29271/jcpsp.2023.05.539.
8
What is the evidence for the role of therapeutic apheresis in the management of complement-associated thrombotic microangiopathies?
Transfus Apher Sci. 2018 Feb;57(1):31-34. doi: 10.1016/j.transci.2018.02.013. Epub 2018 Feb 21.
9
C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy.C5抑制可使癌症及化疗相关血栓性微血管病患者继续接受抗肿瘤治疗。
Blood Adv. 2022 Dec 13;6(23):6071-6074. doi: 10.1182/bloodadvances.2022008395.
10
Thrombotic Microangiopathies with Rheumatologic Involvement.伴有风湿性疾病累及的血栓性微血管病
Rheum Dis Clin North Am. 2018 Nov;44(4):635-649. doi: 10.1016/j.rdc.2018.06.010. Epub 2018 Sep 7.
引用本文的文献
1
Thrombotic Microangiopathy and Multiple Organ Failure in Scleroderma Renal Crisis: A Case Report.硬皮病肾危象中的血栓性微血管病与多器官功能衰竭：一例报告
Cureus. 2023 Aug 29;15(8):e44322. doi: 10.7759/cureus.44322. eCollection 2023 Aug.
本文引用的文献
1
Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis-Induced Thrombotic Microangiopathies.C5抑制在特发性炎性肌病和硬皮病肾危象所致血栓性微血管病中的作用
Kidney Int Rep. 2021 Jan 29;6(4):1015-1021. doi: 10.1016/j.ekir.2021.01.021. eCollection 2021 Apr.
2
Diagnostic and Risk Factors for Complement Defects in Hypertensive Emergency and Thrombotic Microangiopathy.高血压急症和血栓性微血管病中补体缺陷的诊断和危险因素。
Hypertension. 2020 Feb;75(2):422-430. doi: 10.1161/HYPERTENSIONAHA.119.13714. Epub 2019 Dec 23.
3
Complement inhibitors are not useful in secondary hemolytic uremic syndromes.补体抑制剂对继发性溶血性尿毒症综合征无效。
Kidney Int. 2019 Oct;96(4):829-833. doi: 10.1016/j.kint.2019.08.001.
4
Complement inhibitors are useful in secondary hemolytic uremic syndromes.补体抑制剂在继发性溶血性尿毒症综合征中很有用。
Kidney Int. 2019 Oct;96(4):826-829. doi: 10.1016/j.kint.2019.07.006.
5
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.非典型和继发性溶血尿毒综合征具有独特的表现，且无共同的遗传风险因素。
Kidney Int. 2019 Jun;95(6):1443-1452. doi: 10.1016/j.kint.2019.01.023. Epub 2019 Mar 15.
6
Scleroderma renal crisis and renal involvement in systemic sclerosis.硬皮病肾危象与系统性硬化症中的肾脏受累
Nat Rev Nephrol. 2018 Feb;14(2):137. doi: 10.1038/nrneph.2017.183. Epub 2018 Jan 2.
7
Haemolytic uraemic syndrome.溶血尿毒综合征。
Lancet. 2017 Aug 12;390(10095):681-696. doi: 10.1016/S0140-6736(17)30062-4. Epub 2017 Feb 25.
8
Inflammatory muscle diseases.炎性肌病
N Engl J Med. 2015 Apr 30;372(18):1734-47. doi: 10.1056/NEJMra1402225.
9
The spectrum of renal involvement in patients with inflammatory myopathies.炎性肌病患者肾脏受累的范围
Medicine (Baltimore). 2014 Jan;93(1):33-41. doi: 10.1097/MD.0000000000000015.
Zotero 插件